Medscape

An Update on Treatment Strategies for Common Variable Immunodeficiency

Common variable immunodeficiency (CVID) is a primary immunological disease with variable severity, ranging from mild forms of infections to chronic progressive complications. The hallmark of this ...
Nasdaq

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation

Leiden, the Netherlands, March 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has been dosed in a Phase II, proof ...
Self

I Thought I Just Got Sicker Than Other People—Until a Blood Test Led to a Life-Changing Diagnosis

In 2001, Megan Ryan, 46, was diagnosed with common variable immunodeficiency (CVID), one of the most common types of primary immunodeficiency diseases, or PIDDs, which are rare genetic disorders that ...
Nature

The common variable immunodeficiency IgM repertoire narrowly recognizes erythrocyte and platelet glycans

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Medical Xpress

Disease or Syndrome: Common variable immune deficiency

A study just published in the journal Microbiome, describes for the first time the intestinal microbiome and metabolome in patients with (genetically acquired) CTLA4 deficiency. CTLA4 is an immune ...
Monthly Prescribing Reference

FDA Approval Expands Use of Xembify for Primary Immunodeficiency

In treatment-experienced patients, findings showed Xemfiby exposure was similar between weekly and biweekly dosing. The Food and Drug Administration (FDA) has expanded the approval of Xembify ® ...